Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
about
Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@ast
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@en
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@nl
type
label
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@ast
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@en
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@nl
prefLabel
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@ast
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@en
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@nl
P2093
P2860
P356
P1433
P1476
Discovery of monocarbonyl curc ...... sistant breast cancer therapy.
@en
P2093
Dingqiao Xu
Feiyan Liu
Jianpeng Guo
Lingyi Kong
Shanshan Li
Wenda Zhang
Wenying Yu
P2860
P2888
P356
10.1038/SREP46352
P407
P577
2017-04-11T00:00:00Z
P6179
1084757203